Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 13 | 2022 | 571 | 2.270 |
Why?
|
| Insulin Resistance | 4 | 2022 | 353 | 1.510 |
Why?
|
| Adipose Tissue | 5 | 2022 | 259 | 1.280 |
Why?
|
| Obesity | 5 | 2022 | 966 | 0.950 |
Why?
|
| Lysosomes | 2 | 2021 | 111 | 0.930 |
Why?
|
| Neutrophils | 2 | 2021 | 308 | 0.870 |
Why?
|
| Monocytes | 2 | 2021 | 218 | 0.820 |
Why?
|
| Carcinogenesis | 2 | 2021 | 211 | 0.800 |
Why?
|
| Leukocyte Elastase | 1 | 2021 | 8 | 0.780 |
Why?
|
| DNA | 3 | 2021 | 1307 | 0.760 |
Why?
|
| Nanoparticles | 1 | 2021 | 164 | 0.710 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2019 | 152 | 0.670 |
Why?
|
| Interferon-gamma | 2 | 2018 | 451 | 0.560 |
Why?
|
| Neoplasms | 2 | 2021 | 3035 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3209 | 0.530 |
Why?
|
| Atherosclerosis | 1 | 2018 | 255 | 0.500 |
Why?
|
| Energy Metabolism | 3 | 2020 | 277 | 0.350 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 2552 | 0.330 |
Why?
|
| Mice | 12 | 2022 | 11737 | 0.330 |
Why?
|
| Animals | 16 | 2022 | 27317 | 0.320 |
Why?
|
| Histones | 2 | 2021 | 329 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 594 | 0.290 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1650 | 0.270 |
Why?
|
| Phenotype | 5 | 2022 | 2439 | 0.260 |
Why?
|
| Iron Overload | 1 | 2022 | 6 | 0.210 |
Why?
|
| Phagosomes | 2 | 2021 | 39 | 0.210 |
Why?
|
| Iron | 2 | 2022 | 168 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 53 | 0.200 |
Why?
|
| Cross-Priming | 1 | 2021 | 48 | 0.200 |
Why?
|
| Ceramides | 1 | 2021 | 35 | 0.200 |
Why?
|
| Culture Media | 1 | 2021 | 147 | 0.200 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2021 | 4 | 0.200 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2021 | 5 | 0.200 |
Why?
|
| Phagocytosis | 1 | 2021 | 86 | 0.190 |
Why?
|
| Pancreatic Elastase | 1 | 2021 | 15 | 0.190 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2021 | 85 | 0.190 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 67 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 73 | 0.190 |
Why?
|
| fas Receptor | 1 | 2021 | 77 | 0.190 |
Why?
|
| Cyclophosphamide | 1 | 2021 | 299 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 135 | 0.190 |
Why?
|
| Acinetobacter Infections | 1 | 2020 | 17 | 0.190 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 24 | 0.180 |
Why?
|
| Protein Domains | 1 | 2021 | 133 | 0.180 |
Why?
|
| Immunity | 1 | 2021 | 141 | 0.180 |
Why?
|
| Acinetobacter baumannii | 1 | 2020 | 27 | 0.180 |
Why?
|
| Proteolysis | 1 | 2021 | 108 | 0.180 |
Why?
|
| Antigens | 1 | 2021 | 229 | 0.180 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 117 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2021 | 274 | 0.180 |
Why?
|
| Cell Death | 1 | 2021 | 262 | 0.180 |
Why?
|
| Cysteine | 1 | 2020 | 136 | 0.180 |
Why?
|
| Mice, Obese | 2 | 2022 | 44 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2020 | 1990 | 0.170 |
Why?
|
| Proteomics | 1 | 2021 | 230 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 89 | 0.170 |
Why?
|
| Swine | 1 | 2021 | 581 | 0.170 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2019 | 6 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2019 | 92 | 0.170 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 24 | 0.170 |
Why?
|
| Humans | 11 | 2021 | 89063 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 432 | 0.170 |
Why?
|
| Hypochlorous Acid | 1 | 2018 | 5 | 0.160 |
Why?
|
| Gallium | 1 | 2018 | 4 | 0.160 |
Why?
|
| Glycolysis | 1 | 2019 | 135 | 0.160 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 80 | 0.160 |
Why?
|
| Foam Cells | 1 | 2018 | 17 | 0.160 |
Why?
|
| Receptors, Interferon | 1 | 2018 | 31 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2020 | 279 | 0.160 |
Why?
|
| Receptors, LDL | 1 | 2018 | 54 | 0.150 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 99 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2018 | 100 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2019 | 261 | 0.150 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1710 | 0.150 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 106 | 0.150 |
Why?
|
| Autophagy | 2 | 2021 | 159 | 0.150 |
Why?
|
| Weight Loss | 1 | 2019 | 225 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 161 | 0.150 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 243 | 0.150 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 202 | 0.140 |
Why?
|
| Cholesterol | 1 | 2018 | 357 | 0.130 |
Why?
|
| Diet | 1 | 2019 | 442 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2020 | 836 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 506 | 0.130 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2015 | 37 | 0.130 |
Why?
|
| Chemotaxis | 1 | 2015 | 73 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 74 | 0.130 |
Why?
|
| Liver | 1 | 2020 | 1205 | 0.120 |
Why?
|
| Palmitates | 1 | 2014 | 15 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2014 | 103 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 125 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 103 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2014 | 73 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1521 | 0.120 |
Why?
|
| Inflammation | 2 | 2022 | 971 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 104 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 199 | 0.110 |
Why?
|
| Hypoxia | 2 | 2019 | 650 | 0.110 |
Why?
|
| Androgens | 1 | 2013 | 175 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2020 | 1652 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 313 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2013 | 168 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 540 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2013 | 184 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 459 | 0.100 |
Why?
|
| Glucose | 1 | 2014 | 630 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 668 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 249 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 216 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 1108 | 0.090 |
Why?
|
| Adipocytes | 2 | 2022 | 162 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1975 | 0.080 |
Why?
|
| Insulin | 1 | 2014 | 1146 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2880 | 0.080 |
Why?
|
| Female | 4 | 2021 | 46011 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 559 | 0.080 |
Why?
|
| Homeostasis | 2 | 2020 | 413 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2362 | 0.070 |
Why?
|
| Male | 6 | 2020 | 42251 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2021 | 18 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 16 | 0.050 |
Why?
|
| Nanocomposites | 1 | 2021 | 11 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 48 | 0.050 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 23 | 0.050 |
Why?
|
| COS Cells | 1 | 2021 | 167 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2347 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2020 | 112 | 0.040 |
Why?
|
| Multigene Family | 1 | 2020 | 203 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 30 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 280 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 272 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2020 | 175 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 132 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 153 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 213 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 283 | 0.040 |
Why?
|
| Lysine | 1 | 2019 | 150 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 32 | 0.040 |
Why?
|
| Sputum | 1 | 2018 | 35 | 0.040 |
Why?
|
| Oxidants | 1 | 2018 | 86 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2018 | 202 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 75 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2018 | 306 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 198 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 174 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 499 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 387 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 115 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 1487 | 0.040 |
Why?
|
| Calcium | 1 | 2021 | 1172 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 459 | 0.030 |
Why?
|
| Chromatin | 1 | 2019 | 397 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2015 | 9 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2062 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 16 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 88 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 102 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 102 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 247 | 0.030 |
Why?
|
| Castration | 1 | 2013 | 41 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 232 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 814 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2752 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 195 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 786 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1087 | 0.030 |
Why?
|
| Metagenome | 1 | 2013 | 104 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 319 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1214 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 887 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 691 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 576 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 1258 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 191 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 471 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 324 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 751 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1429 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4132 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 6288 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 9237 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 25863 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 26507 | 0.010 |
Why?
|